期刊文献+

低热量肠外营养联合生长激素在老年重症胆管炎病人中的疗效分析 被引量:2

Therapeutic effect of low calorie of parenteral nutrition combined with growth hormone for elderly patients with severe cholangitis
下载PDF
导出
摘要 目的:探讨老年重症胆管炎(acute cholangitis of severe type,ACST)病人给予低热量肠外营养(PN)支持和生长激素(rhGH)治疗的效果。方法:以低热量、低糖、低脂肪为总原则,对50例老年重症胆管炎病人实施PN,总热量不超过63~84 kJ/(kg·d),供氮量不超过0.10~0.12g/(kg·d)。脂肪供热不超过40%,配合短程小剂量rhGH治疗。观察治疗前后血清白蛋白、前白蛋白、转铁蛋白、肌酐指数、总淋巴细胞计数和氯平衡等的变化。结果:治愈46例,死亡4例。治疗过程中未出现明显的糖、脂代谢异常和肝酶谱变化的代谢性并发症。采用低热量PN和生长激素治疗后血浆蛋白水平显著升高,氮平衡、肌酐指数得到明显改善。结论:低热量PN与rhGH联合应用是治疗老年急性重症胆管炎有效的支持方法。 Objective: To evaluate the curative effects of hypocaloric parenteral nutrition (HPN) and recombinant human growth hormone (rhGH) on the senile acute cholangitis of severe type (ACST) patients. Methods: HPN and lower rhGH (Saizen) were given to 50 senile ACST patients in the principle of low calorie, low carbohydrates and low fat. Total energy and nitrogen were supplied 62.8-83.7 kJ/( kg·d ) and 0.10-0.12g/( kg·d ), respectively. The rate of non-protein nitrogen/nitrogen was 100:1-120:1. Lipid energy was supplied in a rate of no more than 40 percent of the energy. Serum albumin, transferrin (TFN), creatine height index (CHI), total lymphocyte count (TLC) and nitrogen balance were determined. Results: 46 cases were cured and 4 died. No complications of abnormal glucose and fat metabolism and liver function occurred in the course of the treatment. The contents of albumin, pre-albumin, transferrin, CHI, TLC increased and nitrogen balance significantly improved after the application of HPN and GH. Conclusion: The associated application of HPN and GH is effective for the senile ACST patients.
作者 何瑞玲
出处 《现代生物医学进展》 CAS 2008年第2期325-326,共2页 Progress in Modern Biomedicine
关键词 低热量肠外营养 生长激素 急性重症胆管炎 Hypocaloric parenteral nutrition Growth hormone (GH) Acute cholangitis of severe type (ACST)
  • 相关文献

参考文献2

二级参考文献12

  • 1Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome [J].Crit Care Med, 1999,27(12):2799-2805.
  • 2Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients[J]?JAMA, 2001,286(8):944-953.
  • 3Vanden Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control [J]. Crit Care Med, 2003,31(2):359-366.
  • 4Moore FA, Feliciano DV, Andrassy R J, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complication. The results of a meta-analysis[J]. Ann Surg, 1992,216(2):172-183.
  • 5Marik PE, Zaloga GP. Early enteral nutrition in acutely ill patients: A systematic review.[J]. Crit Care Med, 2001,29(12):2264-2270.
  • 6van der Hulst RR, Van krell BK, Von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity [J].Lancet, 1993,341 (8857): 1363-1365.
  • 7Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation[J]. Ann Intern Med, 1992,116(10):821-828.
  • 8Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition[J]. Nutrition, 1997,13(4):295-302.
  • 9Goeters C, Wenn A, Mertes N, et al. Parenteral 1-alanyl1-glutamine improves 6-month outcome in critically ill patients[J]. Crit Care Med, 2002,30(9):2032-2037.
  • 10Novak F, Heyland DK, Avenell A, et al. Glutamine supplementation in serious illness: A systematic review of the evidence[J]. Crit Care Med, 2002,30(9):2022-2029.

共引文献47

同被引文献17

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部